From: Abnormal expression of GADD45B in human colorectal carcinoma
Clinicopathological features | n | GADD45B n (%) | χ2 | P |
---|---|---|---|---|
Gender | Â | Â | 0.116 | 0.734 |
 Male | 83 | 59 (71.1%) |  |  |
 Female | 69 | 46 (66.7%) |  |  |
Age (years) | Â | Â | 0.400 | 0.527 |
 <60 | 93 | 66 (71.0%) |  |  |
 >=60 | 59 | 39 (66.1%) |  |  |
Tumor size (cm) | Â | Â | 0.079 | 0.779 |
 <5 | 88 | 60 (68.2%) |  |  |
 >=5 | 64 | 45 (70.3%) |  |  |
Location | Â | Â | 3.143 | 0.076 |
 Colon | 101 | 65 (64.4%) |  |  |
 Rectum | 51 | 40 (78.4%) |  |  |
Gross type | Â | Â | 0.055 | 0.973 |
 Massive | 57 | 42 (70.0%) |  |  |
 Ulcerative | 81 | 57 (68.7%) |  |  |
 Invasive | 8 | 6 (66.7%) |  |  |
Differentiation | Â | Â | 2.280 | 0.320 |
 Well | 5 | 3 (60%) |  |  |
 Moderate | 113 | 75 (66.4%) |  |  |
 Poor | 34 | 27 (79.4%) |  |  |
TNM stage | Â | Â | 2.114 | 0.146 |
 II | 87 | 56 (64.4%) |  |  |
 III | 65 | 49 (75.4%) |  |  |
Relapse | Â | Â | 5.390 | 0.020 |
 Yes | 47 | 37 (78.7%) |  |  |
 No | 90 | 53 (58.9%) |  |  |
Status | Â | Â | 4.269 | 0.039 |
 Survival | 102 | 62 (60.8%) |  |  |
 Death | 35 | 28 (80.0%) |  |  |